GlassScriptPhysician profile
Torrey A Parry
NPI 1326459660
$27,261.95
in general payments reported to CMS, 2019-2025
8 companies · $30.23 in 2025
The $30.23 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
See the full distribution for Sports Medicine (Orthopaedic Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $20K · 2020: $4,040 · 2021: $1,389 · 2022: $385 · 2023: $411 · 2024: $1,007 · 2025: $30.23.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,423 · Travel and Lodging: $24.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,423.47 |
| Travel and Lodging | $24.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $20,000.00 | 2019 | |
| Impactortho, INC. | $2,821.33 | 2020-2024 | |
| Smith+Nephew, INC. | $2,500.00 | 2020 | |
| Stryker Corporation | $1,359.50 | 2020-2024 | Blueprint Patient Specific Instrumentation, Aequalis Perform Reversed, Zipseal 16 Surgical Skin Closure Kit |
| Vericel Corporation | $404.33 | 2023-2025 | Maci |
| Ossio INC | $122.29 | 2023 | |
| Bioventus LLC | $28.30 | 2020 | |
| Abbott Laboratories | $26.20 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Torrey Parry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.